๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Radiotherapy
Clinical trial register · China

Radiotherapy Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 6 Guiyang 1 Shijiazhuang 1 Harbin 1 Wuhan 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai6 Guiyang1 Shijiazhuang1 Harbin1 Wuhan1
All 9 locations
Target enrolment
to

Radiotherapy trials in China

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases
NCT07469267Breast Cancer, Radiotherapy
Fudan University
Not applicable
1,608
Guiyang, Shijiazhuang, Harbin, Wuhan, Changde, Changsha, Dalian, Jinan
2025-10-24
By invitation
Immediate Autologous Tissue Breast Reconstruction and Radiotherapy Strategy After Breast Cancer Surgery
NCT07798466Breast Cancer, Breast Reconstruction, Radiotherapy
Fudan University
Observational
128
Shanghai
2025-09-01
Recruiting
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
NCT06964568Esophageal Carcinoma, Radiotherapy, Immunotherapy
DrugTP
Fudan University
Phase 3
452
Shanghai
2025-02-01
Recruiting
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
NCT06676449Esophageal Carcinoma, Radiotherapy, Immunotherapy
Fudan University
Phase 3
432
Shanghai
2024-11-01
Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
NCT06249321Pancreatic Cancer, Radiotherapy
Fudan University
Phase 2
30
Shanghai
2024-04-01
Recruiting
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
NCT06190782Esophageal Squamous Cell Carcinoma, Oligometastatic Disease, Radiotherapy
Fudan University
Phase 3
354
Shanghai
2022-09-27
Recruiting
Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
NCT04996732Neoplasms, Survival, Surgery, Radiotherapy
Fudan University
Observational
500,000
Shanghai
2008-01-01
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/radiotherapy

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies listing the condition Radiotherapy that also match the filters currently applied.

How many Radiotherapy trials are recruiting in China?

6 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Radiotherapy), 7 studies
PhaseStudiesRecruitingShare
Phase 33342.9%
Observational2128.6%
Not applicable1114.3%
Phase 21114.3%

Most active sponsors

Lead sponsors with the most studies (Radiotherapy)
Lead sponsorStudiesRecruiting
Fudan University76
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.